What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Pain Receptors (Nociceptors): Types and Mechanism

Name: Pain Receptors (Nociceptors): Types and Mechanism
Creator: Dr. Zubair Khalid

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

A pain receptor, or nociceptor, is a specialized peripheral sensory neuron ending that detects stimuli intense enough to threaten tissue and converts that stimulus into an electrical signal. Nociceptors do not detect "pain" directly. They detect noxious mechanical, thermal, or chemical events, and the brain later constructs the experience of pain from that signal.

This distinction matters in veterinary medicine. Nociception is the neural processing of noxious input. Pain is the unpleasant sensory and emotional experience that may follow. An animal under general anesthesia can have intact nociception and reflex withdrawal without experiencing pain, while an animal with chronic osteoarthritis can experience pain with relatively little ongoing noxious input. Understanding nociceptor types, transduction, and the ascending pathways gives clinicians the mechanistic basis for choosing local anesthetics, NSAIDs, opioids, and adjunctive analgesics.

This article covers nociceptor classification, the molecular machinery of transduction, the dorsal root ganglion, the first synapse in the dorsal horn, ascending tracts, and descending modulation. It closes with species notes for birds, fish, and reptiles, and a section on clinical relevance and common mistakes.

What Is a Nociceptor?

A nociceptor is a free nerve ending of a primary afferent neuron whose cell body sits in a dorsal root ganglion (DRG) or a cranial nerve ganglion such as the trigeminal ganglion. The term "free" means the ending lacks the encapsulated structures seen in touch receptors like Pacinian corpuscles. Nociceptor terminals branch through skin, muscle, periosteum, joint capsule, and viscera.

The adequate stimulus for a nociceptor is one that would damage tissue if sustained. Mechanical pressure strong enough to deform tissue, temperatures near or above 43 degrees Celsius or near freezing, and a range of endogenous chemicals released by damaged cells all qualify. Nociceptors also respond to exogenous irritants such as capsaicin from chili peppers and allyl isothiocyanate from mustard oil, which is why these compounds are used experimentally to activate specific nociceptor populations [1].

Nociceptor activation threshold is not fixed. Repeated stimulation, inflammation, and stress can lower the threshold, a process called peripheral sensitization. This is why a joint that was mildly uncomfortable becomes exquisitely painful after a flare.

Nociceptor Classes

Nociceptors are classified by axon diameter, myelination, conduction velocity, and the stimulus modalities they detect. The table below summarizes the main classes.

Fiber type	Diameter (µm)	Conduction velocity (m/s)	Primary stimulus	Typical sensation or role
A-delta (Group III)	1 to 5	5 to 30	Intense mechanical, noxious heat	Sharp, fast, well-localized first pain
C (Group IV)	0.2 to 1.5	0.5 to 2	Mechanical, thermal, chemical (polymodal)	Dull, slow, poorly localized second pain
A-beta (Group II)	6 to 12	30 to 70	Light touch, vibration, hair movement	Innocuous touch, not nociceptive under normal conditions
Silent (sleeping) nociceptors	Mostly C, some A-delta	Low to moderate	None under normal conditions	Recruited after inflammation or tissue injury

A-delta Mechanical Nociceptors

A-delta fibers are thinly myelinated and conduct quickly. They signal the sharp, immediate component of a noxious event. In monkeys, mechano-heat-sensitive A-delta nociceptors in hairy skin fall into two heat-response types: Type I fibers peak late in a 30-second 53 degrees Celsius stimulus, have heat thresholds above 53 degrees Celsius, and conduct at a mean of 25 m/s, while Type II fibers peak within 1 to 3 seconds, have a median heat threshold of 46 degrees Celsius, and conduct at a mean of 15 m/s [2]. Type I fibers sensitize to heat after intense stimulation, and Type II fibers are suppressed. Only Type I fibers were found in glabrous skin, which fits the observation that glabrous skin produces little first pain to heat [2].

C Polymodal Nociceptors

C fibers are unmyelinated and conduct slowly. Most are polymodal, meaning a single ending responds to mechanical, thermal, and chemical stimuli. In the same monkey study, C mechano-heat nociceptors had a median heat threshold of 41 degrees Celsius and a mean response latency of about 100 ms [2]. Their slow conduction and broad receptive fields produce the dull, aching, poorly localized quality of second pain and much of the pain from viscera and deep somatic structures.

A-beta Fibers Are Not Nociceptors

A-beta fibers are large, heavily myelinated, low-threshold mechanoreceptors. They respond to light touch, vibration, and hair deflection. Under normal conditions they do not signal noxious input. They become clinically important in central sensitization, where dorsal horn neurons that normally receive only A-beta input begin to respond to it as if it were noxious. This mechanism contributes to mechanical allodynia, where a light touch produces pain.

Silent Nociceptors

Silent nociceptors are afferents that are unresponsive or minimally responsive to noxious stimuli in healthy tissue. After inflammation or tissue injury, they become responsive and can develop spontaneous activity. They are thought to contribute to the delayed onset and persistence of inflammatory pain and to the spread of tenderness beyond the original injury site.

Transduction: Converting a Noxious Stimulus into a Signal

Transduction is the conversion of a physical or chemical stimulus into a depolarizing current in the nociceptor terminal. This occurs through ion channels that open in response to specific stimuli. The resulting generator potential, if large enough, triggers action potentials that travel to the spinal cord.

TRPV1

Transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel activated by capsaicin, noxious heat, and protons. It is heavily expressed in small-diameter DRG neurons that give rise to C and some A-delta fibers. TRPV1 activity is modulated by inflammatory signaling. In cultured mouse DRG neurons, pretreatment with the TLR-4 agonist lipopolysaccharide enhanced capsaicin-evoked calcium transients, and this potentiation depended on protein kinase A, since the PKA inhibitor KT5720 blocked it [3]. This is a mechanistic example of how infection or inflammation can amplify nociceptor responses.

TRPV1 is also a target for endogenous modulation. Activation of the G-protein coupled estrogen receptor 1 (GPER1) with its agonist G-1 reduced action potential firing rates and TRPV1-mediated calcium influx in human induced pluripotent stem cell-derived nociceptors [4]. This finding helps explain sex differences in some chronic pain conditions.

TRPA1

Transient receptor potential ankyrin 1 (TRPA1) responds to reactive electrophiles such as allyl isothiocyanate, the pungent compound in mustard and wasabi. It is co-expressed with TRPV1 in many polymodal nociceptors. A flavonoid compound, trans-chalcone, reduced nocifensive behavior in mice when tested against both capsaicin (a TRPV1 agonist) and allyl isothiocyanate (a TRPA1 agonist), showing that both channels can be engaged in the same behavioral models [1].

Acid-Sensing Ion Channels

Acid-sensing ion channels (ASICs) are proton-gated channels that open when extracellular pH falls. Tissue injury, ischemia, and inflammation lower local pH, and ASICs contribute to the chemical component of nociceptor activation. They are especially relevant in muscle and cardiac ischemia and in the acidic environment of inflamed joints.

Voltage-Gated Sodium Channels Nav1.7 and Nav1.8

Once a generator potential reaches threshold, voltage-gated sodium channels produce the action potential. Nav1.7 and Nav1.8 are tetrodotoxin-resistant or tetrodotoxin-sensitive channels enriched in nociceptors and are central to excitability.

Nav1.7, encoded by SCN9A, acts as a threshold amplifier. In a human ascending somatosensory assembloid model built from pluripotent stem cells, loss of Nav1.7 disrupted synchronized activity across the circuit, while a gain-of-function SCN9A variant associated with extreme pain disorder induced hypersynchrony [5]. This is direct functional evidence that Nav1.7 shapes how nociceptive signals propagate through the ascending pathway, not just how they start.

Nav1.8 contributes to action potential upstroke in C fibers and helps sustain repetitive firing during inflammation. These channels are the mechanistic reason local anesthetics, which block voltage-gated sodium channels, abolish nociceptive transmission when applied close enough to the nerve.

The Dorsal Root Ganglion

The cell body of each primary afferent sits in the dorsal root ganglion. The DRG is not a passive relay. It is a hub where gene expression, neuropeptide synthesis, and receptor trafficking are regulated. Substance P and calcitonin gene-related peptide (CGRP) are produced here and transported to both the peripheral terminal and the central terminal.

The DRG is also a site of immune-neuronal interaction. In a mouse model of cough variant asthma, chemical ablation of TRPV1-expressing DRG neurons with resiniferatoxin reduced cough frequency, lung inflammation, and levels of substance P and CGRP [6]. In co-culture, TRPV1 activation in DRG neurons promoted substance P release, which drove macrophages toward an M1 pro-inflammatory phenotype through the neurokinin-1 receptor [6]. This demonstrates that DRG neurons are active participants in neurogenic inflammation, not just wires.

The First Synapse in the Dorsal Horn

Primary afferents enter the spinal cord through the dorsal root and terminate in the gray matter of the dorsal horn. The dorsal horn is divided into Rexed laminae, and nociceptive afferents terminate in a characteristic pattern.

Lamina I (marginal layer) receives input from A-delta and C nociceptors, including many that project to the thalamus and parabrachial nucleus.
Lamina II (substantia gelatinosa) receives dense C fiber input and contains interneurons that gate transmission.
Lamina V receives convergent input from A-delta and C fibers as well as low-threshold mechanoreceptors, which is why wide dynamic range neurons here can respond to both touch and noxious stimuli.

Retrograde labeling studies in rats show that spinothalamic tract neurons are located in laminae I, III through VII, and X, while postsynaptic dorsal column neurons are found in laminae III through IV and near the central canal [7]. This anatomical overlap explains why more than one ascending system can carry nociceptive information.

Neurotransmitters at this first synapse include glutamate, which acts on AMPA and NMDA receptors, and neuropeptides such as substance P and CGRP. Glial cells, including microglia and astrocytes, modulate synaptic strength. The P2Y12 receptor on microglia enhances microglial activation and synaptic plasticity of primary sensory neurons, contributing to chronic nociceptive pain that reaches higher centers mainly through the spinothalamic tract [8].

Ascending Pain Pathways

From the dorsal horn, second-order neurons project rostrally through several tracts. The two most discussed are the spinothalamic tract and the spinoreticular tract. A third, the spinoparabrachial pathway, is important for the affective dimension of pain and for some deep tissue inputs.

The main flow of nociceptive information from periphery to cortex can be summarized as follows.

flowchart TD
    A[Noxious stimulus] --> B[Nociceptor terminal]
    B --> C[Transduction channels]
    C --> D[Action potential]
    D --> E[Dorsal root ganglion]
    E --> F[Dorsal horn synapse]
    F --> G[Second order neuron]
    G --> H[Spinothalamic tract]
    G --> I[Spinoreticular tract]
    H --> J[Thalamus]
    I --> K[Brainstem arousal]
    J --> L[Cortex and insula]

Spinothalamic Tract

The spinothalamic tract (STT) is the classic crossed pathway for pain and temperature. Axons cross the midline near their level of entry and ascend in the contralateral anterolateral quadrant. The STT relays to the thalamus, which then projects to somatosensory cortex for localization and intensity, and to insular and cingulate regions for the affective component.

Clinical and imaging evidence supports this role. Diffusion tensor imaging in people with chronic neck and shoulder pain found reduced fractional anisotropy and increased mean diffusivity at specific segments of the cervical STT compared with healthy controls, indicating localized microstructural differences [9][10]. These changes correlated with clinical measures in the same studies, though mean whole-tract values did not differ significantly between groups [9][10].

The STT has been a surgical target for intractable cancer pain. Cordotomy, which interrupts the STT, produces contralateral analgesia, and complications of the procedure have revealed functional relationships between the STT and reticular, spinocerebellar, and autonomic pathways [11]. Neurosurgical reviews note that since the introduction of intrathecal opioids, the need for destructive procedures such as cordotomy, trigeminal tractotomy, and dorsal root entry zone operations has declined, but these procedures remain options for selected cancer pain patients [12].

Spinoreticular Tract

The spinoreticular tract projects to the reticular formation of the brainstem. It contributes to arousal, autonomic responses, and the affective dimension of pain. Because it feeds into the reticular activating system, it helps explain why pain disrupts sleep and produces vigilance even when the sensory-discriminative component is modest.

Spinoparabrachial Pathway

The spinoparabrachial pathway projects to the lateral parabrachial nucleus and is important for the emotional and autonomic aspects of pain. In a rat study of acute bone nociception, no dorsal horn neurons activated by bone drilling projected to the thalamus or gracile nucleus, but 12.2 percent of spinoparabrachial projection neurons contained Fos-like immunoreactivity after bone drilling, significantly more than the 3.4 percent in sham controls [13]. This suggests that deep somatic pain from bone may rely more on the spinoparabrachial pathway than on the STT, which has implications for understanding why bone pain can be so distressing and poorly relieved by some interventions.

Postsynaptic Dorsal Column Pathway

The postsynaptic dorsal column (PSDC) pathway carries visceral nociceptive information. In rats, ureter distention evoked Fos expression in both PSDC and STT neurons, with PSDC neurons representing a significantly higher percentage of retrogradely labeled cells in some laminae [7]. Limited midline myelotomy, which transects dorsal column fibers, provides pain relief in some patients with visceral cancer pain, which is clinical evidence for the PSDC role in visceral nociception [7].

Descending Modulation

The brain does not passively receive nociceptive input. It sends descending projections that can facilitate or inhibit dorsal horn transmission. The periaqueductal gray, rostral ventromedial medulla, and dorsolateral pontine tegmentum are key sources. These regions project to the dorsal horn through the dorsolateral funiculus and release serotonin, norepinephrine, and endogenous opioids.

Descending inhibition is the mechanism behind stress-induced analgesia and the analgesic effect of some tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors. Descending facilitation contributes to chronic pain states, where the balance shifts toward amplification.

The interaction between ascending and descending systems is complex. Lesions to both somatic and affective pain pathways in cancer patients led to decreased salience network connectivity, showing that pain relief changes functional brain network topology, not just local activity [14]. This is a reminder that pain is distributed across networks.

Pharmacology at the Nociceptor and Beyond

Analgesic drugs act at multiple points along this pathway. Knowing the site of action helps predict which drug will help which pain.

NSAIDs

Nonsteroidal anti-inflammatory drugs inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis in injured tissue. Prostaglandins sensitize nociceptor terminals, so reducing them raises the activation threshold and reduces peripheral sensitization. NSAIDs act mainly peripherally but have some central effects. They are most useful for inflammatory and musculoskeletal pain.

Opioids

Opioids act on mu, kappa, and delta opioid receptors. These are G-protein coupled receptors that reduce neuronal excitability by inhibiting calcium channels and activating potassium channels. Opioid receptors are present on primary afferents, dorsal horn neurons, and in descending modulatory circuits. Intrathecal opioids have largely replaced destructive neurosurgical procedures for many cancer pain patients [12]. Opioids can produce analgesia without abolishing nociception, which is one reason they are valuable in balanced anesthesia.

Local Anesthetics

Local anesthetics block voltage-gated sodium channels, preventing action potential generation and propagation. Applied at a nerve trunk or infiltrated at a surgical site, they abolish nociceptive transmission from that region. They do not reduce inflammation or central sensitization, so they are most effective when used before or during the noxious event rather than after central changes have developed.

Adjunctive Agents

Compounds that modulate TRPV1, TRPA1, or downstream signaling are under investigation. Protectin DX, a specialized pro-resolving mediator, reduced inflammatory pain in mice by inhibiting TRPV1 activity and nociceptive neuron activation, without altering basal mechanical or thermal sensitivity or motor activity [15]. Trans-chalcone reduced both TRPV1- and TRPA1-mediated nocifensive behavior [1]. GPER1 activation reduced nociceptor firing [4]. These findings point toward future analgesics that target specific transduction channels rather than broadly suppressing the nervous system.

Species Notes

Birds

Birds have fewer nociceptors than mammals in some tissues, but they show clear behavioral and physiological responses to noxious stimuli. They withdraw from noxious heat, guard injured limbs, and alter feeding and vocalization after injury. The anatomical differences do not justify withholding analgesia. Birds have opioid receptors and respond to mu-opioid agonists, though dose and species differences matter. NSAIDs such as meloxicam are widely used in avian practice.

Fish

Fish have nociceptors and opioid receptors. They respond to noxious stimuli with behavioral changes including altered swimming, reduced feeding, and rubbing of the affected area. Opioid administration reduces these responses. The presence of nociceptors and opioid receptors, combined with behavioral evidence, supports the position that fish can experience pain and should receive analgesia when noxious procedures are performed.

Reptiles

Reptiles are less studied than mammals, birds, and fish. They have nociceptive circuitry and respond to noxious stimuli, but the density and distribution of nociceptor subtypes are not well characterized. Clinical experience supports the use of opioids and NSAIDs in reptiles, but dosing is often extrapolated from other taxa and should be guided by species-specific references when available.

Mammals

Domestic mammals, including dogs, cats, horses, cattle, pigs, and small rodents, share the nociceptor classes and ascending pathways described above. Species differences exist in receptor distribution, drug metabolism, and behavioral expression of pain. Cats, for example, are deficient in glucuronidation and require different NSAID dosing than dogs. Horses can develop laminitis and colic pain that involve deep somatic and visceral nociceptors. Pigs are increasingly used in translational pain research because of similarities to human anatomy.

Clinical Relevance, Limitations and Common Mistakes

The most common mistake is equating nociception with suffering. A reflex withdrawal under anesthesia is not evidence of pain perception. Conversely, an animal that is quiet and still after surgery may be in significant pain. Veterinarians use composite pain scales, behavioral observation, and physiological monitoring to assess pain, and they treat based on the likelihood of pain given the procedure and the patient's condition.

A second mistake is assuming that a single analgesic will cover all nociceptive mechanisms. Inflammatory pain, neuropathic pain, visceral pain, and bone pain involve different receptor populations and pathways. Bone pain, for example, appears to rely heavily on the spinoparabrachial pathway rather than the STT [13], which may explain why some STT-targeted interventions provide incomplete relief.

A third mistake is delaying analgesia until pain is obvious. Preemptive and multimodal analgesia, using local anesthetics, NSAIDs, and opioids together, reduces peripheral and central sensitization and improves outcomes.

A fourth mistake is extrapolating doses across species without accounting for metabolic differences. This is especially relevant for NSAIDs in cats and for opioids in birds and reptiles.

Individual animals vary in their response to pain and to analgesics. A veterinarian who knows the patient, the procedure, and the species-specific pharmacology should make treatment decisions.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

Frequently Asked Questions

What is a pain receptor?

A pain receptor, or nociceptor, is a free nerve ending of a primary sensory neuron that detects noxious mechanical, thermal, or chemical stimuli and converts them into electrical signals.

Do all animals feel pain the same way?

No. Nociceptor density, receptor distribution, ascending pathway organization, and behavioral expression differ across species. Birds, fish, reptiles, and mammals all have nociceptive circuitry, but the subjective experience cannot be assumed to be identical.

What is the difference between A-delta and C fibers?

A-delta fibers are thinly myelinated and conduct quickly, producing sharp, well-localized first pain. C fibers are unmyelinated and conduct slowly, producing dull, poorly localized second pain.

Why does inflammation make pain worse?

Inflammation lowers nociceptor threshold through prostaglandins, protons, and other mediators that sensitize TRPV1, ASICs, and sodium channels. This is called peripheral sensitization.

What is central sensitization?

Central sensitization is increased excitability of dorsal horn and higher neurons after prolonged nociceptive input. It can cause allodynia, where light touch produces pain, and hyperalgesia, where mildly noxious stimuli produce intense pain.

How do opioids reduce pain?

Opioids activate G-protein coupled receptors on nociceptors, dorsal horn neurons, and descending modulatory circuits, reducing neuronal excitability and transmitter release.

How do NSAIDs reduce pain?

NSAIDs inhibit cyclooxygenase and reduce prostaglandin synthesis, which raises nociceptor threshold and reduces peripheral sensitization.

Can fish feel pain?

Fish have nociceptors and opioid receptors, and they show behavioral and physiological responses to noxious stimuli that are reduced by analgesics. Current evidence supports treating fish as capable of experiencing pain.